Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 4
2004 5
2005 7
2006 6
2007 7
2008 6
2009 11
2010 11
2011 5
2012 9
2013 6
2014 5
2015 5
2016 3
2017 9
2018 3
2019 5
2020 12
2021 19
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Results by year
Filters applied: . Clear all
Page 1
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis.
Tajik N, Frech M, Schulz O, Schälter F, Lucas S, Azizov V, Dürholz K, Steffen F, Omata Y, Rings A, Bertog M, Rizzo A, Iljazovic A, Basic M, Kleyer A, Culemann S, Krönke G, Luo Y, Überla K, Gaipl US, Frey B, Strowig T, Sarter K, Bischoff SC, Wirtz S, Cañete JD, Ciccia F, Schett G, Zaiss MM. Tajik N, et al. Among authors: uberla k. Nat Commun. 2020 Apr 24;11(1):1995. doi: 10.1038/s41467-020-15831-7. Nat Commun. 2020. PMID: 32332732 Free PMC article.
Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.
Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-Ladner U, Niehues T, Überla K, Vygen-Bonnet S, Weinke T, Wiese-Posselt M, Wojcinski M, Zepp F. Wagner N, et al. Among authors: uberla k. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019. PMID: 30899964 German. No abstract available.
IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
Hahn F, Wangen C, Häge S, Peter AS, Dobler G, Hurst B, Julander J, Fuchs J, Ruzsics Z, Überla K, Jäck HM, Ptak R, Muehler A, Gröppel M, Vitt D, Peelen E, Kohlhof H, Marschall M. Hahn F, et al. Among authors: uberla k. Viruses. 2020 Dec 5;12(12):1394. doi: 10.3390/v12121394. Viruses. 2020. PMID: 33291455 Free PMC article.
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.
Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss MM, Heppt F, Meder C, Atreya R, Klenske E, Dietrich P, Abdullah A, Kliem T, Corte G, Morf H, Leppkes M, Kremer AE, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Maier C, Hueber AJ, Manger K, Manger B, Berking C, Tenbusch M, Überla K, Sticherling M, Neurath MF, Schett G. Simon D, et al. Among authors: uberla k. Nat Commun. 2020 Jul 24;11(1):3774. doi: 10.1038/s41467-020-17703-6. Nat Commun. 2020. PMID: 32709909 Free PMC article.
Early Mortality of Brain Cancer Patients and its Connection to Cytomegalovirus Reactivation During Radiochemotherapy.
Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, Dörfler A, Engelhorn T, Eyüpoglu I, Rühle PF, Putz F, Semrau S, Gaipl US, Fietkau R. Goerig NL, et al. Among authors: uberla k. Clin Cancer Res. 2020 Jul 1;26(13):3259-3270. doi: 10.1158/1078-0432.CCR-19-3195. Epub 2020 Feb 14. Clin Cancer Res. 2020. PMID: 32060103 Free article.
Biographical Feature: Bernhard Fleckenstein.
Thoma-Kress AK, Desrosiers RC, Gack MU, Jung JU, Überla K, Kirchhoff F. Thoma-Kress AK, et al. Among authors: uberla k. J Virol. 2021 Aug 10;95(17):e0089621. doi: 10.1128/JVI.00896-21. Epub 2021 Aug 10. J Virol. 2021. PMID: 34191579 No abstract available.
Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination.
Heß R, Storcksdieck Genannt Bonsmann M, Lapuente D, Maaske A, Kirschning C, Ruland J, Lepenies B, Hannaman D, Tenbusch M, Überla K. Heß R, et al. Among authors: uberla k. Viruses. 2019 Feb 13;11(2):153. doi: 10.3390/v11020153. Viruses. 2019. PMID: 30781796 Free PMC article.
129 results